FDA Investigator Sneha S Patel
Sneha S Patel has conducted inspections on 31 sites in 14 countries as of 10 Feb 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
31
Last Inspection Date:
10 Feb 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Italy,
Canada,
Poland,
United States of America,
Sweden,
Czechia,
Portugal,
Germany,
India,
France,
Switzerland,
Japan,
Spain,
Belgium
FDA Investigators that have inspected at least one site in common with Sneha S Patel:
Adam J Wilson,
Adam R Cooke,
Adam S Freeman,
Alan L Truong,
Alan M Barker,
Alan P Kurtzberg,
Alanna L Mussawwir Bias,
Alexandra A Carrico,
Alison N Stieg,
Amanda M Dunneback,
Anastasia I Onuorah,
Anastasia M Shields,
Andrea J Schmidt,
Andrew J Barrowcliff,
Andrew J Lang,
Angela E Glenn,
Ann L Demarco,
Anna Lazar,
Anthony C Warchut,
Arsen Karapetyan,
Art O Czabaniuk,
Atul J Agrawal,
Azza Talaat,
Barbara Janine Breithaupt,
Barbara M Frazier,
Benjamin J Dastoli,
Brent M Dehaan,
Brittany A Mckenzie,
Brooke K Higgins,
Brooke K Seeman,
Camerson E Moore,
Caroline H Le,
Caroline Strasinger,
CDR Ileana Barreto Pettit,
CDR Rochelle B Young, RPh, MSA,
Chaltu Nwakijra,
Charanjeet Jassal,
Charles L Zhou,
Charles M Edwards,
Charles R Cote, RIC,
Charles Yuanchia Kuo, PhD,
Cheryl M Monroe,
Chris A Sack,
Christina Capacci Daniel, PhD,
Christopher T Middendorf,
Concepcion Cruz, Jr,
Constance Y Fears,
Constantin Y Philopoulos,
Courtney E Hillier,
Cristina Ausin Moreno, PhD,
Daniel J Brown,
Daniel J Lahar,
Darla J Christopher,
Darren S Morgan,
Deborah M Trout,
Dell S Moller,
Dennis E Swartz,
Dennis L Doupnik,
Diane L Raccasi,
Diane T Bargo,
Diane T O'brien,
Dipesh K Shah,
Donald L Lech,
Douglas A Campbell,
Douglas C Kovacs,
Dylan C Grippi,
Eboni S Funderburk,
Edwin Jao,
Elizabeth Ll Edwards,
Emest F Bizjak,
Emilie E Kahn,
Emily J Orban,
Erika V Butler,
Esther C Broner, PhD,
Farhana Khan,
Felix Maldonado,
Francis A Guidry,
Frederick F Razzaghi,
Frederick M Lochner,
Gam S Zamil,
Guerlain Ulysse,
Gwyn G Dickinson,
Hala L Selby,
Hyung Yul Lee,
Ivis L Negron,
Jacob G Lutz,
James A Lane,
James L Dunnie, Jr,
James M Mason,
James P Mcreavey,
James R Evans,
Janet A Rajan,
Janet L Bowen,
Jason F Chancey,
Jeffery A Hangartner,
Jeffrey D Meng,
Jennifer L Gustavus,
Joey V Quitania,
Jogy George,
John P Mistler,
Johnna L Bleem,
Jon P Antoniou,
Jonathan W Chapman,
Jorge L Guadalupe,
Jose Acruz Gonzalez,
Jose M Cayuela,
Jose R Hernandez,
Joseph A Piechocki,
Joslyn K Brunelle, PhD,
Julie D Bringger,
June P Page,
Karen M Kondas,
Katelyn Astaub Zamperini,
Katherine Szestypalow,
Kathleen D Culver,
Kathryn G Brown,
Kevin P Foley,
Ko U Min,
Kristen D Evans,
Kshitij A Patkar,
L'oreal F Walker,
Lance A Finnical,
Laureen M Geniusz,
Laurie B Frazier,
Lawrence Harmon, Jr,
Lawrence J Stringer,
LCDR Chad N Thompson,
LCDR Debra Emerson,
LCDR Sean Byrd,
Leslie A Paul,
Linda S Jozefiak,
Linda Thai,
Lisa Hayka,
Logan T Williams,
LT Skip A Payne,
LTJG Aaron B Otis,
Luis A Dasta,
Maida Henesian (NMI),
Marcus A Ray,
Marcus F Yambot,
Margaret M Annes,
Maria A Ruttell,
Maria Cruz Fisher,
Marie A Fadden,
Mark E Parmon,
Marlon K Turner,
Martha Sullivan Myrick,
Mary E Storch,
Massoud Motamed,
Matthew B Casale,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Melissa J Garcia,
Melissa T Roy,
Miah I Schneider,
Michael A Charles,
Michael E Clark,
Michael E Maselli,
Michael L Casner,
Michael P Sheehan,
Michael R Goga,
Michael Shanks, MS,
Michael Y Philopoulos,
Michele L Forster, PhD,
Michele L Obert,
Michele Perry Williams,
Michelle L Jones,
Michelle Marsh,
Milva E Melendez Perales,
Mra B Kamberem,
Mra Davism,
Mra Mcculloughj,
Muna Algharibeh,
Muralidhara B Gavini, PhD,
Nancy M Espinal,
Nicholas J Presto,
Nicholas L Paulin,
Owens,
Patrice S Hall,
Patsy J Domingo,
Paul A Bonneau,
Paula A Trost,
Paula J Bretz,
Peter E Baker,
Phenicia T Petty,
Phenicia T Wedgeworth,
Pratik S Upadhyay, DDC,
Qin Xu,
Rabia Ballica, PhD,
Rabin N Ghoshal,
Rafeeq A Habeeb,
Ralph A Erickson,
Rasha Bamieh,
Raymond T Oji,
Rebecca E Dombrowski,
Rebecca Rodriguez,
Regina T Brown,
Reginald Walker,
Richard E Needham,
Richard L Friedman,
Robert Barbosa,
Robert D Tollefsen,
Robert Jennings,
Robert M Barbosa,
Rochelle L Cross,
Rodney G Raiford,
Rohn R Robertson,
Rose Ashley,
Russell J Glapion,
Saied A Asbagh,
Saleem A Akhtar,
Salwa K Poole,
Sandra A Boyd,
Sangeeta M Khurana, PhD,
Sanket N Patel,
Sarah E Mcmullen,
Sarah M Meng,
Sarah M Napier,
Sargum C Sood,
Satheesh Thomas,
Scott R Nichols, PhD,
Sean R Marcsisin,
Shankar L Saha,
Simone E Pitts,
Soyinka S Eneng,
Stephen J Kilker,
Steven C Madzo,
Steven M Weinman,
Susan F Laska, MS,
Susan M Jackson,
Susanne M Richardson, MS RAC,
Tamara M Kays,
Tamika White,
Tamil Arasu, PhD,
Teresa I Navas,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tiffani D Wilson,
Timothy J Schmidt,
Tina M Pawlowski,
Tonnie L Carter,
Towanda L Terrell,
Toyin B Oladimeji,
Tracey Asinjen Wiersma,
Truong Xuan Nguyen (Andy),
Twana R Chandler,
Ucheabuchi Cchudi Nwankwor,
Vaishali J Patel,
Valerie L Whipp,
Vanessa J Colburn,
Wayne E Seifert,
Wendy G Tan, PhD,
William A Warnick,
William D Tingley,
William L Bargo,
Yanming An, PhD,
Yasamin Ameri,
Yong Hu,
Yuan Chia Kuo,
Yumi J Hiramine,
Yvins Dezan,
Zachary L Miller
Sneha S Patel's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| November, 2013 | FDA 483 | Corden Pharma Bergamo SpA - Form 483, 2013-11-08 |
| November, 2019 | FDA 483 | KYOWA HAKKO BIO CO., LTD. - Form 483, 2019-11-08 |
| December, 2010 | FDA 483 | Ash Stevens LLC - Form 483, 2010-12-22 |
| March, 2014 | FDA 483 Response | Elba, Inc. - Form 483R, 2014-04-10 |
| May, 2011 | FDA 483 | Ben Venue Laboratories Inc. - Form 483, 2011-05-25 |
| February, 2020 | EIR | Hetero Drugs Limited - EIR, 2020-04-17 |
| November, 2011 | FDA 483 | Corium Innovations, Inc - Form 483, 2011-11-07 |
| July, 2016 | FDA 483 | IPSEN PHARMA BIOTECH - Form 483, 2016-07-12 |
| March, 2014 | FDA 483 | Elba, Inc. - Form 483, 2014-04-01 |
| August, 2017 | FDA 483 | Mylan Pharmaceuticals Inc. - Form 483, 2017-08-25 |
| June, 2013 | EIR | Catalent Indiana, LLC - EIR, 2013-06-17 |
| February, 2020 | FDA 483 | Hetero Drugs Limited - Form 483, 2020-02-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more